Promising therapy for relapsed patients with aggressive form of lymphoma
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.
The Auxiliary … it’s about caring
As The Auxiliary approaches its 80th anniversary, it continues to gain strength and vitality through the dedication, effort, energy, talent and creativity of its legion of volunteers.
Pioneering effort to apply novel biotechnology to cancer research
The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.
Partnership supports cancer-fighting
power of protein analysis
Dr. Christoph Borchers has established the first pan-Canadian proteomics program, custom-tailoring cancer treatments to meet the needs of individual patients